A deep eutectic-based, self-emulsifying subcutaneous depot system for apomorphine therapy in Parkinson’s disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A deep eutectic-based, self-emulsifying subcutaneous depot system for apomorphine therapy in Parkinson’s disease
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 119, Issue 9, Pages e2110450119
Publisher
Proceedings of the National Academy of Sciences
Online
2022-02-24
DOI
10.1073/pnas.2110450119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral delivery of sorafenib through spontaneous formation of ionic liquid nanocomplexes
- (2020) Yujie Shi et al. JOURNAL OF CONTROLLED RELEASE
- Self-Emulsifying Drug Delivery Systems: Hydrophobic Drug Polymer Complexes Provide a Sustained Release in Vitro
- (2020) Ahmad Malkawi et al. MOLECULAR PHARMACEUTICS
- Clinical Translation of Choline and Geranic Acid Deep Eutectic Solvent
- (2020) Justin Ko et al. Bioengineering & Translational Medicine
- Prolonged Delivery of Apomorphine Through the Buccal Mucosa, Towards a Noninvasive Sustained Administration Method in Parkinson's Disease: In Vivo Investigations in Pigs
- (2020) Constantin Itin et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Effective encapsulation of apomorphine into biodegradable polymeric nanoparticles through a reversible chemical bond for delivery across the blood–brain barrier
- (2019) Jeremy Pang Kern Tan et al. Nanomedicine-Nanotechnology Biology and Medicine
- Old Drugs, New Delivery Systems in Parkinson’s Disease
- (2019) Harsh V. Gupta et al. DRUGS & AGING
- Promising disease-modifying therapies for Parkinson’s disease
- (2019) Valina L. Dawson et al. Science Translational Medicine
- Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
- (2019) S. Rahima Benhabbour et al. Nature Communications
- Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
- (2019) C Warren Olanow et al. LANCET NEUROLOGY
- ND0701, A Novel Formulation of Apomorphine for Subcutaneous Infusion, in Comparison to a Commercial Apomorphine Formulation: 28-Day Pharmacokinetic Study in Minipigs and a Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Relative Bioavailability
- (2018) Yuval Ramot et al. CNS DRUGS
- Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
- (2018) Regina Katzenschlager et al. LANCET NEUROLOGY
- Challenges and trends in apomorphine drug delivery systems for the treatment of parkinson's disease
- (2017) Nrupa Borkar et al. Asian Journal of Pharmaceutical Sciences
- Practical management of adverse events related to apomorphine therapy
- (2016) Roongroj Bhidayasiri et al. PARKINSONISM & RELATED DISORDERS
- Apomorphine - pharmacological properties and clinical trials in Parkinson's disease
- (2016) Peter Jenner et al. PARKINSONISM & RELATED DISORDERS
- Lipophilic prodrugs of apomorphine I: Preparation, characterisation, and in vitro enzymatic hydrolysis in biorelevant media
- (2015) Nrupa Borkar et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- PLGA microparticles with zero-order release of the labile anti-Parkinson drug apomorphine
- (2013) C. Regnier-Delplace et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Oral Apomorphine Delivery from Solid Lipid Nanoparticles with Different Monostearate Emulsifiers: Pharmacokinetic and Behavioral Evaluations
- (2010) Ming-Jun Tsai et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Quantitative Risk Analysis for N-Methyl Pyrrolidone Using Physiologically Based Pharmacokinetic and Benchmark Dose Modeling
- (2009) Torka S. Poet et al. TOXICOLOGICAL SCIENCES
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started